Show
Sort by
-
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response : a sub-study of the NEAT001/ANRS143 randomized trial
-
- Journal Article
- A1
- open access
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
-
- Journal Article
- A1
- open access
Validation of a novel multivariate method of defining HIV-associated cognitive impairment
-
Structural brain abnormalities in successfully treated HIV infection : associations with disease and cerebrospinal fluid biomarkers
-
- Journal Article
- A1
- open access
The 'COmorBidity in Relation to AIDS' (COBRA) cohort : design, methods and participant characteristics
-
- Journal Article
- A1
- open access
High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid
-
- Journal Article
- A1
- open access
Increased brain-predicted aging in treated HIV disease